|
US11111543B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US11111544B2
(en)
|
2005-07-29 |
2021-09-07 |
Natera, Inc. |
System and method for cleaning noisy genetic data and determining chromosome copy number
|
|
US9424392B2
(en)
|
2005-11-26 |
2016-08-23 |
Natera, Inc. |
System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
|
|
US12221653B2
(en)
|
2010-05-18 |
2025-02-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11322224B2
(en)
|
2010-05-18 |
2022-05-03 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
EP2854058A3
(en)
|
2010-05-18 |
2015-10-28 |
Natera, Inc. |
Methods for non-invasive pre-natal ploidy calling
|
|
US12152275B2
(en)
|
2010-05-18 |
2024-11-26 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US20190010543A1
(en)
|
2010-05-18 |
2019-01-10 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11939634B2
(en)
|
2010-05-18 |
2024-03-26 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11332793B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US10316362B2
(en)
|
2010-05-18 |
2019-06-11 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11408031B2
(en)
|
2010-05-18 |
2022-08-09 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
US11326208B2
(en)
|
2010-05-18 |
2022-05-10 |
Natera, Inc. |
Methods for nested PCR amplification of cell-free DNA
|
|
US11339429B2
(en)
|
2010-05-18 |
2022-05-24 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
US9677118B2
(en)
|
2014-04-21 |
2017-06-13 |
Natera, Inc. |
Methods for simultaneous amplification of target loci
|
|
US11332785B2
(en)
|
2010-05-18 |
2022-05-17 |
Natera, Inc. |
Methods for non-invasive prenatal ploidy calling
|
|
AU2011348100B2
(en)
|
2010-12-22 |
2016-08-25 |
Natera, Inc. |
Methods for non-invasive prenatal paternity testing
|
|
JP6153874B2
(ja)
|
2011-02-09 |
2017-06-28 |
ナテラ， インコーポレイテッド |
非侵襲的出生前倍数性呼び出しのための方法
|
|
EP3246416B1
(en)
|
2011-04-15 |
2024-06-05 |
The Johns Hopkins University |
Safe sequencing system
|
|
US20140100126A1
(en)
|
2012-08-17 |
2014-04-10 |
Natera, Inc. |
Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
|
|
WO2014070462A1
(en)
|
2012-10-29 |
2014-05-08 |
The Johns Hopkins University |
Papanicolaou test for ovarian and endometrial cancers
|
|
RU2717641C2
(ru)
|
2014-04-21 |
2020-03-24 |
Натера, Инк. |
Обнаружение мутаций и плоидности в хромосомных сегментах
|
|
US20180173845A1
(en)
|
2014-06-05 |
2018-06-21 |
Natera, Inc. |
Systems and Methods for Detection of Aneuploidy
|
|
EP4428863A3
(en)
|
2015-05-11 |
2024-12-11 |
Natera, Inc. |
Methods and compositions for determining ploidy
|
|
US10453556B2
(en)
|
2015-07-23 |
2019-10-22 |
The Chinese University Of Hong Kong |
Analysis of fragmentation patterns of cell-free DNA
|
|
US11286531B2
(en)
|
2015-08-11 |
2022-03-29 |
The Johns Hopkins University |
Assaying ovarian cyst fluid
|
|
KR102326769B1
(ko)
|
2016-03-25 |
2021-11-17 |
카리우스, 인코포레이티드 |
합성 핵산 스파이크-인
|
|
JP7280044B2
(ja)
|
2016-04-15 |
2023-05-23 |
ナテラ， インコーポレイテッド |
肺癌の検出方法
|
|
WO2018067517A1
(en)
|
2016-10-04 |
2018-04-12 |
Natera, Inc. |
Methods for characterizing copy number variation using proximity-litigation sequencing
|
|
GB201618485D0
(en)
|
2016-11-02 |
2016-12-14 |
Ucl Business Plc |
Method of detecting tumour recurrence
|
|
US10011870B2
(en)
|
2016-12-07 |
2018-07-03 |
Natera, Inc. |
Compositions and methods for identifying nucleic acid molecules
|
|
IL302912A
(en)
|
2016-12-22 |
2023-07-01 |
Guardant Health Inc |
Methods and systems for analyzing nucleic acid molecules
|
|
WO2018137685A1
(en)
|
2017-01-25 |
2018-08-02 |
The Chinese University Of Hong Kong |
Diagnostic applications using nucleic acid fragments
|
|
EP3635134A4
(en)
*
|
2017-06-09 |
2021-03-03 |
Bellwether Bio, Inc. |
DIAGNOSTIC CANCER OR OTHER PHYSIOLOGICAL CONDITIONS USING CIRCULATING NUCLEIC ACID FRAGMENT SENTINEL END POINTS
|
|
JP7181900B2
(ja)
*
|
2017-06-15 |
2022-12-01 |
ノボ・ノルデイスク・エー／エス |
患者プロファイルに基づくインスリン滴定アルゴリズム
|
|
CN110741438B
(zh)
|
2017-06-15 |
2023-12-29 |
诺和诺德股份有限公司 |
具有适应性靶葡萄糖水平的基础滴定
|
|
WO2019016353A1
(en)
*
|
2017-07-21 |
2019-01-24 |
F. Hoffmann-La Roche Ag |
CLASSIFICATION OF SOMATIC MUTATIONS FROM A HETEROGENEOUS SAMPLE
|
|
KR20250047324A
(ko)
|
2017-08-07 |
2025-04-03 |
더 존스 홉킨스 유니버시티 |
암을 평가하고 치료하기 위한 방법 및 재료
|
|
WO2019060716A1
(en)
|
2017-09-25 |
2019-03-28 |
Freenome Holdings, Inc. |
SAMPLE EXTRACTION METHODS AND SYSTEMS
|
|
US11728007B2
(en)
*
|
2017-11-30 |
2023-08-15 |
Grail, Llc |
Methods and systems for analyzing nucleic acid sequences using mappability analysis and de novo sequence assembly
|
|
WO2019118926A1
(en)
|
2017-12-14 |
2019-06-20 |
Tai Diagnostics, Inc. |
Assessing graft suitability for transplantation
|
|
EP3737773B1
(en)
|
2018-01-12 |
2023-04-12 |
Natera, Inc. |
Novel primers and uses thereof
|
|
EP3743518A4
(en)
*
|
2018-01-24 |
2021-09-29 |
Freenome Holdings, Inc. |
METHODS AND SYSTEMS FOR DETECTING ANOMALY IN PATTERNS OF NUCLEIC ACIDS
|
|
US20210002728A1
(en)
*
|
2018-02-27 |
2021-01-07 |
Cornell University |
Systems and methods for detection of residual disease
|
|
IL276891B2
(en)
|
2018-02-27 |
2025-05-01 |
Univ Cornell |
Highly sensitive detection of circulating DNA using genome-wide integration
|
|
US11767562B2
(en)
|
2018-03-08 |
2023-09-26 |
St. John's University |
Circulating serum cell-free DNA biomarkers and methods
|
|
US12626780B2
(en)
|
2018-03-13 |
2026-05-12 |
Grail, Inc. |
Method and system for selecting, managing, and analyzing data of high dimensionality
|
|
WO2019178563A1
(en)
*
|
2018-03-15 |
2019-09-19 |
The Board Of Trustees Of Leland Stanford Junior University |
Methods using nucleic acid signals for revealing biological attributes
|
|
CA3095030A1
(en)
*
|
2018-03-30 |
2019-10-03 |
Juno Diagnostics, Inc. |
Deep learning-based methods, devices, and systems for prenatal testing
|
|
EP3776555A2
(en)
*
|
2018-04-13 |
2021-02-17 |
Grail, Inc. |
Multi-assay prediction model for cancer detection
|
|
WO2019200410A1
(en)
*
|
2018-04-13 |
2019-10-17 |
Freenome Holdings, Inc. |
Machine learning implementation for multi-analyte assay of biological samples
|
|
DK3781714T3
(da)
|
2018-04-14 |
2026-03-30 |
Natera Inc |
Fremgangsmåder til cancerpåvisning og -overvågning ved personlig påvisning af cirkulerende tumor-dna
|
|
CN112888459B
(zh)
|
2018-06-01 |
2023-05-23 |
格里尔公司 |
卷积神经网络系统及数据分类方法
|
|
WO2020006369A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Guardant Health, Inc. |
Methods and systems for analysis of ctcf binding regions in cell-free dna
|
|
US12234509B2
(en)
|
2018-07-03 |
2025-02-25 |
Natera, Inc. |
Methods for detection of donor-derived cell-free DNA
|
|
US20200075124A1
(en)
*
|
2018-09-04 |
2020-03-05 |
Guardant Health, Inc. |
Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
|
|
EP3815005A4
(en)
*
|
2018-10-08 |
2022-03-30 |
Freenome Holdings, Inc. |
Transcription factor profiling
|
|
GB201818159D0
(en)
*
|
2018-11-07 |
2018-12-19 |
Cancer Research Tech Ltd |
Enhanced detection of target dna by fragment size analysis
|
|
WO2020106987A1
(en)
*
|
2018-11-21 |
2020-05-28 |
Karius, Inc. |
Detection and prediction of infectious disease
|
|
EP4700161A3
(en)
|
2018-11-21 |
2026-03-11 |
Karius, Inc. |
Direct-to-library methods, systems, and compositions
|
|
US10468141B1
(en)
*
|
2018-11-28 |
2019-11-05 |
Asia Genomics Pte. Ltd. |
Ancestry-specific genetic risk scores
|
|
US11581062B2
(en)
|
2018-12-10 |
2023-02-14 |
Grail, Llc |
Systems and methods for classifying patients with respect to multiple cancer classes
|
|
CN113366122B
(zh)
*
|
2018-12-19 |
2024-01-12 |
香港中文大学 |
游离dna末端特征
|
|
CN113195741A
(zh)
*
|
2018-12-21 |
2021-07-30 |
豪夫迈·罗氏有限公司 |
从循环核酸中鉴定全基因组序列数据中的全局序列特征
|
|
US20200219587A1
(en)
*
|
2018-12-21 |
2020-07-09 |
Grail, Inc. |
Systems and methods for using fragment lengths as a predictor of cancer
|
|
WO2020150258A1
(en)
*
|
2019-01-15 |
2020-07-23 |
Luminist, Inc. |
Methods and systems for detecting liver disease
|
|
KR20260023068A
(ko)
*
|
2019-01-24 |
2026-02-20 |
일루미나, 인코포레이티드 |
장기 건강 및 질환을 모니터링하기 위한 방법 및 시스템
|
|
EP4567131A3
(en)
|
2019-01-31 |
2025-09-03 |
Guardant Health, Inc. |
Compositions and methods for isolating cell-free dna
|
|
US11475978B2
(en)
|
2019-02-12 |
2022-10-18 |
Tempus Labs, Inc. |
Detection of human leukocyte antigen loss of heterozygosity
|
|
AU2020221847B2
(en)
|
2019-02-12 |
2026-04-02 |
Tempus Ai, Inc. |
Detection of Human Leukocyte Antigen loss of heterozygosity
|
|
WO2020172435A1
(en)
*
|
2019-02-20 |
2020-08-27 |
The Regents Of The University Of California |
System and method for tissue classification using quantitative image analysis of serial scans
|
|
WO2020176659A1
(en)
*
|
2019-02-27 |
2020-09-03 |
Guardant Health, Inc. |
Methods and systems for determining the cellular origin of cell-free dna
|
|
EP3956466A1
(en)
*
|
2019-04-15 |
2022-02-23 |
Natera, Inc. |
Improved liquid biopsy using size selection
|
|
US12497662B2
(en)
|
2019-04-16 |
2025-12-16 |
Grail, Inc. |
Systems and methods for tumor fraction estimation from small variants
|
|
EP4425506A3
(en)
*
|
2019-05-22 |
2024-12-04 |
Grail, Inc. |
Systems and methods for determining whether a subject has a cancer condition using transfer learning
|
|
EP3976822A1
(en)
|
2019-05-31 |
2022-04-06 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
US12305235B2
(en)
|
2019-06-06 |
2025-05-20 |
Natera, Inc. |
Methods for detecting immune cell DNA and monitoring immune system
|
|
WO2021007462A1
(en)
*
|
2019-07-09 |
2021-01-14 |
The Translational Genomics Research Institute |
METHODS OF DETECTING DISEASE AND TREATMENT RESPONSE IN cfDNA
|
|
WO2021016441A1
(en)
*
|
2019-07-23 |
2021-01-28 |
Grail, Inc. |
Systems and methods for determining tumor fraction
|
|
EP4018003A1
(en)
*
|
2019-08-28 |
2022-06-29 |
Grail, LLC |
Systems and methods for predicting and monitoring treatment response from cell-free nucleic acids
|
|
CN110706749B
(zh)
*
|
2019-09-10 |
2022-06-10 |
至本医疗科技（上海）有限公司 |
一种基于组织器官分化层次关系的癌症类型预测系统和方法
|
|
EP4041919A1
(en)
|
2019-09-30 |
2022-08-17 |
Guardant Health, Inc. |
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
WO2021072275A1
(en)
*
|
2019-10-11 |
2021-04-15 |
Guardant Health, Inc. |
Use of cell free bacterial nucleic acids for detection of cancer
|
|
ES3031713T3
(en)
|
2019-11-26 |
2025-07-10 |
Guardant Health Inc |
Methods, compositions and systems for improving the binding of methylated polynucleotides
|
|
WO2021107676A1
(ko)
*
|
2019-11-29 |
2021-06-03 |
주식회사 녹십자지놈 |
인공지능 기반 염색체 이상 검출 방법
|
|
EP4077735A4
(en)
*
|
2019-12-20 |
2024-01-24 |
AccuraGen Holdings Limited |
METHOD AND SYSTEMS FOR DETECTING DISEASES
|
|
EP4081655B1
(en)
*
|
2019-12-24 |
2026-03-18 |
Vib Vzw |
Disease detection in liquid biopsies
|
|
WO2021163546A1
(en)
|
2020-02-14 |
2021-08-19 |
The Johns Hopkins University |
Methods and materials for assessing nucleic acids
|
|
JP2023516633A
(ja)
*
|
2020-02-28 |
2023-04-20 |
グレイル リミテッド ライアビリティ カンパニー |
メチル化シークエンシングデータを使用したバリアントをコールするためのシステムおよび方法
|
|
WO2021222828A1
(en)
|
2020-04-30 |
2021-11-04 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
WO2021236993A1
(en)
|
2020-05-22 |
2021-11-25 |
Bloodq, Inc. |
Methods for characterizing cell-free nucleic acid fragments
|
|
AU2021291586B2
(en)
*
|
2020-06-19 |
2024-02-15 |
University Health Network |
Multimodal analysis of circulating tumor nucleic acid molecules
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4407042A3
(en)
|
2020-07-10 |
2024-09-18 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
ES3018032T3
(en)
|
2020-07-30 |
2025-05-14 |
Guardant Health Inc |
Methods for isolating cell-free dna
|
|
WO2022040163A1
(en)
*
|
2020-08-18 |
2022-02-24 |
Delfi Diagnostics, Inc. |
Methods and systems for cell-free dna fragment size densities to assess cancer
|
|
WO2022046947A1
(en)
|
2020-08-25 |
2022-03-03 |
Guardant Health, Inc. |
Methods and systems for predicting an origin of a variant
|
|
WO2022061080A1
(en)
*
|
2020-09-17 |
2022-03-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
|
|
JP2023544720A
(ja)
|
2020-09-30 |
2023-10-25 |
ガーダント ヘルス， インコーポレイテッド |
Ｄｎａメチル化分配アッセイのシグナル対ノイズ比を改善するための方法およびシステム
|
|
WO2022087309A1
(en)
|
2020-10-23 |
2022-04-28 |
Guardant Health, Inc. |
Compositions and methods for analyzing dna using partitioning and base conversion
|
|
EP4251765A1
(en)
|
2020-11-30 |
2023-10-04 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
CN114634982A
(zh)
*
|
2020-12-15 |
2022-06-17 |
广州市基准医疗有限责任公司 |
一种检测多核苷酸变异的方法
|
|
EP4015650A1
(en)
*
|
2020-12-18 |
2022-06-22 |
Nipd Genetics Biotech Limited |
Methods for classifying a sample into clinically relevant categories
|
|
EP4267757A1
(en)
|
2020-12-23 |
2023-11-01 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
WO2022174109A1
(en)
|
2021-02-12 |
2022-08-18 |
Guardant Health, Inc. |
Methods and compositions for detecting nucleic acid variants
|
|
WO2022204730A1
(en)
|
2021-03-25 |
2022-09-29 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
WO2022216981A1
(en)
*
|
2021-04-08 |
2022-10-13 |
Delfi Diagnostics, Inc. |
Method of detecting cancer using genome-wide cfdna fragmentation profiles
|
|
AU2022255198A1
(en)
*
|
2021-04-08 |
2023-11-23 |
Fred Hutchinson Cancer Center |
Cell-free dna sequence data analysis method to examine nucleosome protection and chromatin accessibility
|
|
WO2022248844A1
(en)
*
|
2021-05-24 |
2022-12-01 |
University Of Essex Enterprises Limited |
Method and system for identifying genomic regions with condition sensitive occupancy/positioning of nucleosomes and/or chromatin
|
|
KR102927037B1
(ko)
*
|
2021-05-28 |
2026-02-13 |
주식회사 지씨지놈 |
조직 특이적 조절 지역의 무세포 dna 분포를 이용한 인공지능 기반 암 조기진단 방법
|
|
CN113838533B
(zh)
*
|
2021-08-17 |
2024-03-12 |
福建和瑞基因科技有限公司 |
一种癌症检测模型及其构建方法和试剂盒
|
|
CN118451200A
(zh)
*
|
2021-11-17 |
2024-08-06 |
小利兰·斯坦福大学托管委员会 |
用于从细胞游离dna推断基因表达和起源组织的系统和方法
|
|
KR102884871B1
(ko)
*
|
2022-01-26 |
2025-11-11 |
권창혁 |
암 판별 장치 및 암 판별 방법
|
|
WO2023142311A1
(zh)
*
|
2022-01-28 |
2023-08-03 |
深圳华大生命科学研究院 |
利用血浆游离dna预测孕期肿瘤组织来源的模型及其构建方法
|
|
US20230323473A1
(en)
*
|
2022-03-03 |
2023-10-12 |
Helio Health Inc. |
Methods for multimodal epigenetic sequencing assays
|
|
EP4489011A4
(en)
*
|
2022-03-03 |
2025-08-06 |
Lunit Inc |
METHOD AND APPARATUS FOR PATHOLOGICAL SLIDE IMAGE ANALYSIS
|
|
KR20250010581A
(ko)
*
|
2022-03-17 |
2025-01-21 |
델피 다이아그노스틱스, 인코포레이티드 |
단편화 프로파일을 사용한 암 모니터링 방법
|
|
JP2025513786A
(ja)
|
2022-04-07 |
2025-04-30 |
ガーダント ヘルス， インコーポレイテッド |
無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出
|
|
EP4532762A4
(en)
*
|
2022-06-02 |
2026-06-03 |
Univ Leland Stanford Junior |
MONOMOLECULAR SEQUENCING AND ESTABLISHMENT OF THE CELLULAR DNA METHYLATION PROFILE
|
|
JP2025522763A
(ja)
|
2022-06-30 |
2025-07-17 |
ガーダント ヘルス， インコーポレイテッド |
異常にメチル化されたｄｎａの富化
|
|
US20240043935A1
(en)
*
|
2022-07-29 |
2024-02-08 |
Centre For Novostics Limited |
Epigenetics analysis of cell-free dna
|
|
JP2025532196A
(ja)
|
2022-09-27 |
2025-09-29 |
ガーダント ヘルス， インコーポレイテッド |
免疫細胞ｄｎａを定量するための方法
|
|
CN115295074B
(zh)
*
|
2022-10-08 |
2022-12-16 |
南京世和基因生物技术股份有限公司 |
基因标志物在恶性肺结节筛查中的应用、筛查模型的构建方法和检测装置
|
|
WO2024112643A1
(en)
*
|
2022-11-21 |
2024-05-30 |
Foundation Medicine, Inc. |
Fragmentomics based identification of tumor-specific copy number alteration states in liquid biopsy
|
|
WO2024137880A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
WO2024138180A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
WO2024233502A1
(en)
|
2023-05-05 |
2024-11-14 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
CN116665784B
(zh)
*
|
2023-05-31 |
2025-12-30 |
华中农业大学 |
基于cfDNA全基因组测序数据识别染色质开放区域的方法、癌症预测模型及系统
|
|
CN121729505A
(zh)
*
|
2023-07-14 |
2026-03-24 |
纳特拉公司 |
测定循环肿瘤dna的方法
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
EP4758267A1
(en)
|
2023-08-11 |
2026-06-17 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
CN117230165A
(zh)
*
|
2023-09-01 |
2023-12-15 |
深圳湾实验室 |
一种无创产前检测胎儿染色体拷贝数异常的优化方法
|
|
EP4781415A1
(en)
|
2023-09-19 |
2026-07-29 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025076452A1
(en)
|
2023-10-06 |
2025-04-10 |
Guardant Health, Inc. |
Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
|
|
WO2025144650A1
(en)
*
|
2023-12-28 |
2025-07-03 |
Genecentric Therapeutics, Inc. |
Method for using circulating tumor dna for cancer subtyping
|
|
WO2025160265A1
(en)
*
|
2024-01-24 |
2025-07-31 |
Predicine, Inc. |
Systems and methods of fragmentomics analysis in cancer
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025205006A1
(ja)
*
|
2024-03-29 |
2025-10-02 |
ソニーグループ株式会社 |
分析方法、クロマチン状態を分類する方法、がん検査方法、分析システム、がん又は微小残存病変の検査システムおよび分析キット
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
WO2026043718A1
(en)
|
2024-08-21 |
2026-02-26 |
Guardant Health, Inc. |
Methods to monitor patients treated with a cancer vaccine
|
|
WO2026073140A1
(en)
|
2024-09-27 |
2026-04-02 |
Guardant Health, Inc. |
Framework to identify genomic regions indicative of one or more biological conditions
|
|
WO2026076332A1
(en)
|
2024-10-03 |
2026-04-09 |
Guardant Health, Inc. |
Methods involving multi-modal tumor variant identification and tracking of tumor molecules
|
|
WO2026090570A1
(en)
|
2024-10-24 |
2026-04-30 |
Guardant Health, Inc. |
Detecting the presence of a biological condition based on a nucleic acid sample data analysis
|
|
WO2026107204A1
(en)
|
2024-11-14 |
2026-05-21 |
Guardant Health, Inc. |
Methods for analyzing low-depth genome sequencing data to detect minimal residual disease
|
|
WO2026136560A1
(en)
|
2024-12-17 |
2026-06-25 |
Guardant Health, Inc. |
Methods for cfdna methylation data modeling using transformer neural network architecture
|
|
CN119905148B
(zh)
*
|
2024-12-30 |
2026-02-06 |
西藏自治区农牧科学院水产科学研究所 |
一种核间等位基因表达分析方法、装置及存储介质
|
|
WO2026165504A1
(en)
|
2025-01-31 |
2026-08-06 |
Guardant Health, Inc. |
Methods for detecting nucleic acids from cancer cells
|
|
CN120334449B
(zh)
*
|
2025-06-20 |
2025-09-05 |
陕西右任故里茯砖茶股份有限公司 |
基于液相色谱的茯砖茶中金花菌发酵检测方法
|